FDA Expresses Concern Over Drugs Made in Emerging Drug Markets

FDA Expresses Concern Over Drugs Made in Emerging Drug Markets July 2, 2014 3rd Party Ecosystem | Pharmaceutical | Risk Assessment | Risk Assessment & Compliance | Third Party Risks Have you ever been treated with a generic medicine or an over-the-counter (OTC) drug? Then chances are high that you have taken a medication made […]